Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.
BACKGROUND
Congenital heart disease (CHD) is the most common type of birth defect with family- and population-based studies supporting a strong genetic cause for CHD. The goal of this study was to determine whether a whole exome sequencing (WES) approach could identify pathogenic-segregating variants in multiplex CHD families.


METHODS AND RESULTS
WES was performed on 9 kindreds with familial CHD, 4 with atrial septal defects, 2 with patent ductus arteriosus, 2 with tetralogy of Fallot, and 1 with pulmonary valve dysplasia. Rare variants (<1% minor allele frequency) that segregated with disease were identified by WES, and variants in 69 CHD candidate genes were further analyzed. These selected variants were subjected to in silico analysis to predict pathogenicity and resulted in the discovery of likely pathogenic mutations in 3 of 9 (33%) families. A GATA4 mutation in the transactivation domain, p.G115W, was identified in familial atrial septal defects and demonstrated decreased transactivation ability in vitro. A p.I263V mutation in TLL1 was identified in an atrial septal defects kindred and is predicted to affect the enzymatic functionality of TLL1. A disease-segregating splice donor site mutation in MYH11 (c.4599+1delG) was identified in familial patent ductus arteriosus and found to disrupt normal splicing of MYH11 mRNA in the affected individual.


CONCLUSIONS
Our findings demonstrate the clinical utility of WES to identify causative mutations in familial CHD and demonstrate the successful use of a CHD candidate gene list to allow for a more streamlined approach enabling rapid prioritization and identification of likely pathogenic variants from large WES data sets.


CLINICAL TRIAL REGISTRATION
URL: https://clinicaltrials.gov; Unique Identifier: NCT0112048.
['LaHaye|Stephanie|S|', 'Corsmeier|Don|D|', 'Basu|Madhumita|M|', 'Bowman|Jessica L|JL|', 'Fitzgerald-Butt|Sara|S|', 'Zender|Gloria|G|', 'Bosse|Kevin|K|', 'McBride|Kim L|KL|', 'White|Peter|P|', 'Garg|Vidu|V|']
D000293:Adolescent D002478:Cells, Cultured D002648:Child D002675:Child, Preschool D003198:Computer Simulation D004252:DNA Mutational Analysis D030541:Databases, Genetic D004374:Ductus Arteriosus, Patent D059472:Exome D005260:Female D050991:GATA4 Transcription Factor D005787:Gene Frequency D005819:Genetic Markers D020022:Genetic Predisposition to Disease D055106:Genome-Wide Association Study D006330:Heart Defects, Congenital D006344:Heart Septal Defects, Atrial D040941:Heredity D059014:High-Throughput Nucleotide Sequencing D006801:Humans D007223:Infant D008297:Male D008957:Models, Genetic D009154:Mutation D059645:Mutation Rate D018995:Myosin Heavy Chains D010375:Pedigree D010641:Phenotype D012307:Risk Factors D013771:Tetralogy of Fallot D055394:Tolloid-Like Metalloproteinases
exome tetralogy of Fallot ductus arteriosus, patent genetic testing heart septal defects, atrial